SAN FRANCISCO, CA (MARKET WIRE) AmStem Corporation (OTCBB: AMST), a world leader in stem cell research using stem cells collected from the umbilical cord immediately after birth, announced today the launch of a new consumer-based study of its flagship cosmeceutical product SteMixx™.

